Dextran safety

For decades, Dextran has been widely used in various products for human use, including IV, IM, oral, and topical applications, in regions such as the US and Europe. Its applications include plasma volume expansion, eye drops, and oral medications like Spasfon and Opalmon.

Dextran's safety profile is well established, holding the Generally Recognized As Safe (GRAS) label from the US FDA, renewed in 2013. This long history of safe use is acknowledged by regulatory authorities globally when setting toxicological, preclinical, and clinical requirements.

For decades Dextran has had the Generally Recognized As Safe (GRAS) label from the US FDA, which was renewed in 2013.